A Phase I Dosing Study of IkT-148009.
Clinical trial NCT06641557 · COMPLETED
Trial details
- NCT number
- NCT06641557
- Sponsor
- ABLi Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2023-03-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.